NV-ALVARIA.
13.9.2022 15:01:49 CEST | Business Wire | Press release
Today, Alvaria, Inc. is pleased to announce the successful deployment of Alvaria Cloud™ in Google Cloud Platform (GCP). Adding GCP to their current offerings of AWS and Azure expands the available public cloud options Alvaria provides to support customer experience (CX) and employee engagement (EX) strategies.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220913005584/en/
Alvaria CEO, Jeff Cotten rehearses "The Modern Contact Center" for opening day at ACE 2022 where he unveils a new engagement framework, The Alvaria Enterprise Modernization Journey (Photo: Business Wire)
Providing multiple public cloud selections, including GCP, is a part of the commitment Alvaria has made to provide choice for customers in order to meet their business objectives with the proper products and services. As an enterprise CCaaS vendor, Alvaria now provides industry leading support to help enterprise brands with complex and specific configuration requirements evolved to meet the needs of rapidly evolving customer expectations.
ACE 2022, Alvaria U kicks off at 9:00 AM PDT with The Modern Contact Center, an address from Chief Executive Officer, Jeff Cotten. He will unveil a new engagement framework, The Alvaria Enterprise Modernization Journey.
“We will assist customers through a process of determining business and technology objectives, with a goal of understanding where they are today and the desired end state,” said Jeff Cotten. “We will then map the best fit of products and services that align to their business goals because with Alvaria you are not going to hear and see a one-size-fits-all approach. We aim to enable choice and flexibility.”
In addition to the CEO Address, Alvaria has a full agenda planned for former Aspect Software, Noble Systems and Alvaria customers and partners including new product demonstrations, insights from industry experts, as well as product tips and tricks and a special keynote, Customer Obsession: How to Satisfy Inherently Unsatisfiable Customers, by Gibson Biddle, Entrepreneur, Advisor, Former Netflix VP Product Management.
Core to the success of ACE each year is the participation of Alvaria Partners. Alvaria would like to thank a select group of partners who have sponsored the event: Call Design, Communik.me, CS Infocomm, ITFor, Resolutte, Rich Communication Technology, Rising Interactions and Waterfield Technologies. Furthermore, this year, Alvaria introduced the ACE Partner Certified Seller track, designed to enable Alvaria partners worldwide with tools to win business.
Alvaria SVP of Global Marketing, Colleen Sheley said, “The pandemic has greatly emphasized the need for enterprises to be resilient, secure and continue to deliver exceptional customer experiences. Brands want to invest in accelerating their consumer technology initiatives and now with the deployment of Alvaria Cloud in GCP there's now less friction and more choice than ever before.”
Registration for the virtual event is still open. Get complimentary access with code: VIRTUAL-ACE22-BEMYGUEST
To register, please visit www.alvaria.com/ace
Alvaria was founded through the merger of Aspect Software and Noble Systems. We are the world leader in enterprise-scale customer experience (CX) and workforce engagement management (WEM) solutions. Our name is derived from Latin for “hives” – nature’s perfect form for millions of years – bringing you solutions that are scalable, resilient and secure, with efficiency, speed and pinpoint accuracy. ALVARIA™. Reshaping Customer Experience™. For more information, please visit www.alvaria.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220913005584/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alsym Energy Announces Na-Series Battery Success Developed With Physics-Informed AI Platform27.4.2026 21:25:00 CEST | Press release
Alsym’s proprietary physics-informed AI platform powered the development of its Na-Series batteries—a non-flammable, high performance and low cost energy solution positioned to serve critical energy storage markets including data centers, utilities, telecommunications, commercial real estate, industrial and defense, among others. Alsym Energy, a pioneer in non-flammable, high-performance sodium-ion batteries, today announced details of the proprietary physics-informed AI platform used to develop the company’s recently launched Na-Series sodium-ion batteries. By integrating fundamental physics models with AI, autonomous testing and proprietary molecular diagnostics in a closed-loop system, Alsym is accelerating the design of safer, inexpensive, commercialized batteries through all phases of the development cycle. As global demand for electricity surges, the limitations of lithium-ion batteries have become increasingly apparent, particularly around safety and supply chain constraints. Li
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release
As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release
Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release
Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
